Reports of changes in libido and sexual desire are among the experiences some people on GLP-1 medications describe — and they go in both directions. In a July 2025 survey conducted by Kinsey Institute researchers and reported by Indiana University, approximately 52% of GLP-1 medication users said the medication had affected their sex lives in some way — 18% reported increased sexual desire and 16% reported decreased desire. If something has shifted since starting GLP-1 medication, there are plausible reasons for it — and it is something worth tracking and discussing with a healthcare provider.
What the Research Shows — and Why It Points Both Ways
The picture that emerges from available data is genuinely mixed — not because the evidence is weak, but because the experience itself varies considerably from person to person.
In a July 2025 survey conducted by Kinsey Institute researchers Dr. Justin Lehmiller and Dr. Amanda Gesselman and reported by Indiana University, approximately 52% of GLP-1 medication users reported that the medication had affected their sex lives in some way — 18% said their sexual desire had increased, while 16% said it had decreased.
Both increases and decreases were real and reported at nearly equal rates — not all in one direction. The survey included 2,000 single U.S. adults ages 18 to 91, balanced to represent the U.S. population across age, gender, household income, geographic region, and race/ethnicity. Because the sample was limited to single adults, the findings may not represent all GLP-1 users — including those in long-term relationships — and the survey was a self-report instrument, not a peer-reviewed clinical trial. Dr. Lehmiller noted that libido effects of these medications are due to a large number of factors — including both the direct effects of the drug on the body and brain, and potential side effects.
A 2024 study published in Brain Sciences used a different method: researchers analyzed social media discussions posted by GLP-1 medication users across online forums over several years (Arillotta et al., 2024). The findings aligned with the survey data in one key way — the experiences were not uniform. Some users described increased libido; others reported decreased interest or uncertainty about whether the medication was the cause. The authors noted that the experiences varied considerably across individuals.
What both sources share is this: the variation is real, the changes are reported at meaningful rates, and neither direction should be dismissed. This is not a topic with a clean, single answer — which is exactly why tracking it personally tends to be more useful than looking for a universal pattern.
Changes in both directions are real — 18% reported increased desire, 16% reported decreased. Neither experience is unusual.
Why Some People Report More Desire
Several indirect pathways may explain why some people on GLP-1 medications describe increased sexual desire. These are not direct effects in the sense of a medication acting immediately on libido — they tend to be downstream of other changes the medication produces.
Changes in energy and how people feel in their bodies
Some people report feeling more physically comfortable and confident as the early weeks progress. For those who have spent years feeling self-conscious about their bodies, experiencing physical changes — more energy, less discomfort after eating, looser clothing — can shift how they feel about themselves. Several GLP-1 users in online discussions have described feeling, for the first time in a long time, more comfortable in their own skin — and noting that this seemed connected to a renewed interest in closeness and intimacy.
This pathway — physical changes influencing self-perception, which in turn may affect desire — is indirect and not universal. Some people describe it; others do not.
Mood shifts that some people report
Some people describe a lifting of low mood or a reduction in feeling anxious during GLP-1 use — and for some, that kind of shift seems connected to more interest in intimacy. For others, the mood picture runs differently (more on this in the next section). Mood changes on GLP-1 medications are genuinely varied and not fully understood — see our article on the emotional side effects some GLP-1 users report for a fuller look at what the research says. If mood is a concern in either direction, it is worth discussing with a provider.
Quieter mental space
For some people, one of the most significant changes on a GLP-1 medication is a reduction in constant preoccupation with food — what some call "food noise." As discussed in our piece on food noise and GLP-1 medications, many users describe getting mental space back that had previously been occupied by persistent food-related thoughts. For some people, that freed bandwidth has felt relevant to desire and connection — though this experience is not universal, and the relationship between quieted food preoccupation and libido is indirect.
Why Libido Sometimes Dips
Decreased interest in sex is reported just as frequently as increased interest, and the reasons are at least as varied.
Fatigue and nausea in the early weeks
Fatigue and low energy are among the most commonly reported early experiences on GLP-1 medications. As covered in our article on managing fatigue on GLP-1 medications, the early weeks often involve reduced caloric intake and the body adjusting — both of which can affect energy. Nausea, also common in the early period, adds another layer of physical discomfort. It would be surprising if this did not affect interest in intimacy for some people. Some users describe this period simply: not interested in much of anything, just getting through the day.
For many people, this kind of reduced interest is tied to early side effects that tend to settle over time. It is not necessarily a reflection of what the longer-term picture will look like.
Sleep disruption affecting energy and interest
Some people report changes in sleep during GLP-1 use — difficulty staying asleep, or increased vividness in dreams, or a particular restlessness in the earlier hours of the night. The sleep changes some GLP-1 users describe are discussed separately, but it is worth noting that disrupted or poor-quality sleep can affect energy and interest in intimacy for some people, separate from any changes in appetite or weight. This pathway — disrupted sleep affecting overall vitality, which in turn may affect desire — is indirect and tends to resolve as sleep patterns stabilize.
Emotional blunting and feeling flat
For some people, the quieting of the brain's reward response to food — which reduces the "pull" of eating — seems to extend to other sources of pleasure and interest as well. Some GLP-1 users describe this as emotional blunting or "feeling flat." As covered in the emotional changes article, this experience varies widely: some people find the quieter feeling welcome; others find it reduces enthusiasm for things they used to look forward to, including intimacy. This is not a universal experience, and it tends to vary considerably over time.
If low mood or feeling flat is a concern, it is worth discussing with a healthcare provider rather than waiting it out.
Some people also report that shifts in desire have affected how connected they feel with a partner. If this is a concern, it is a reasonable thing to raise directly with a healthcare provider.
What May Be Behind the Shifts
GLP-1 medications were not designed with sexual desire as a target. The changes people report appear to be indirect — downstream of other things the medication affects.
One factor that researchers have pointed to is the location of GLP-1 receptors. As covered in our piece on emotional and mood changes on GLP-1, GLP-1 receptors are present not only in the gut but also in parts of the brain involved in reward, motivation, and mood. The same brain circuitry that responds to food and other sources of reward is also involved in desire and motivation more broadly — though the relationship between GLP-1 receptor activity in the brain and sexual desire specifically is still being studied and is not fully understood.
Another pathway involves the broader hormonal picture. Some researchers have noted that body composition changes can affect hormone levels in ways that may influence sexual desire — though these relationships are complex, not yet fully understood, and vary considerably across individuals. If energy or other physical changes seem connected to shifts in libido, these are patterns worth tracking and bringing to a provider. There may be several factors involved, and a provider who knows someone's full health picture is better positioned to evaluate them than a general article.
The honest summary is this: GLP-1 medications affect many systems, and libido changes likely reflect the interaction of several of those systems at once. No single explanation accounts for all the variation in what people report.
Questions to Raise with Your Provider
Many people find that changes in libido are hard to bring up at a routine appointment — especially in a short visit, and especially with a topic that can feel personal or uncertain. Having a few specific questions ready before the appointment tends to make the conversation easier. These are not the kinds of questions that require a long preamble — a provider who works with GLP-1 medications will typically be familiar with this topic.
Bringing a list of questions to a short appointment helps. The provider does not need context — a direct question is enough to open the conversation.
If sexual desire has increased:
- "Is it common for people on GLP-1 medications to notice changes in sexual desire — in either direction? I've been noticing an increase and wanted to mention it."
- "I've been tracking this since starting the medication. Here's what I've noticed: [describe the pattern]. Does this tell you anything useful, or is it something you'd want to keep an eye on?"
If sexual desire has decreased:
- "I've noticed less interest in sex since starting this medication. That's something I hadn't expected — is it worth noting in my chart?"
- "Could energy levels or sleep changes be contributing to what I'm experiencing — and if so, is there anything worth tracking between now and my next visit?"
- "Could other factors in my health history be contributing to this — things that may not be directly related to the medication?"
Either way:
- "Are there things worth tracking between now and my next appointment that would help you understand this better? I'd rather bring you something useful than just a general description."
- "When would a change like this be a reason to follow up sooner rather than waiting for a scheduled visit?"
Using Your Journal to Spot Your Own Pattern
One challenge with libido changes is that they are difficult to attribute to a single cause — and memory tends to smooth out patterns that are actually quite variable day to day. Keeping a simple log makes those patterns visible.
Some useful things to note alongside the date:
- Energy level (scale of 1–10, or a word: high / moderate / low)
- Sleep quality the night before (roughly how many hours, how rested)
- Nausea or GI discomfort (present or not, and intensity)
- Mood (general tone: lifted / neutral / flat / low)
- Interest in intimacy (general sense: more than usual / about the same / less than usual)
This is not a clinical tracking system — it is a personal record. The goal is to give a provider something concrete to work with when the conversation comes up. A note like "Lower interest in weeks 3–6, then it seemed to even out" is far more useful in an appointment than "It's been different, I think."
The GLP-1 Journal tracker is designed for exactly this kind of observation — recording how things are going over time, privately, so the information is there when it is needed.
Tracking log example:
Week 3: Energy low (4/10). Nausea most evenings. Libido: notably lower than before.
Week 8: Energy better (7/10). Nausea has settled. Libido: closer to baseline.
Week 14: Energy stable. Sleep better. Libido: similar to pre-medication or slightly higher some days.
This kind of record — even kept informally — gives a provider something to respond to. "It changed around week 3, improved by week 8, and has been different from baseline since week 10" is a usable clinical description.
This content is for informational and educational purposes only and is not intended as medical advice, diagnosis, or treatment. The information provided reflects patterns reported in surveys and research and does not represent what any individual will experience. Always consult a qualified healthcare provider before making decisions about your health or medications. If you are experiencing a medical emergency, call 911.